Post-operative visual outcomes good with new trifocal IOL

Posted on

One-month post-operative visual outcomes for patients implanted with a new trifocal IOL (PanOptix; Alcon) at a single site were good when compared to predicted refraction, according to data presented at the 2021 ASCRS Annual Meeting.

Researchers analyzed 1-month post-operative visits for 218 eyes implanted with the IOL. Mean monocular and binocular uncorrected distance visual acuity (UCDVA) was 20/24.

Overall, 44.72% of eyes were 20/20 or better; 84.86% of eyes were 20/25 or better; 94.95% of eyes were 20/30 or better; and 99.54% of eyes were 20/40 or better.

Mean binocular UCDVA was 20/22. Of the binocular cases, 62.82% were 20/20 or better; 97.44% were 20/25 or better; and 100% were 20/30 or better.

Mean monocular and binocular uncorrected near visual acuity (UCNVA) was J1 and J1+.

In 59.63% of cases, changes were made using ORA intraoperative aberrometry, including IOL power changed in 36.92%, toric model in 42.31%, and IOL power and toric model changed in 20.77%.

Hu JG, et al. Evaluation of a New Trifocal IOL. Presented at: 2021 ASCRS Annual Meeting.

Related Articles
Patient satisfaction high after bilateral implantation with new trifocal IOL
Jul 25, 2021
Intrascleral IOL fixation with hook-shaped haptic-IOL effective for eyes with insufficient capsular support
Jul 08, 2021
Study cautions use of multifocal intraocular lenses in patients with dAMD, glaucoma
Jul 06, 2021
Click to access the login or register cheese